Schedule 13G ownership disclosure

Anacor Pharmaceuticals Inc

Security class unavailable · CUSIP: 032420101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
970,696
Percent of class
2.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000790502-16-000062
Form type
SC 13G/A
Filer
Anacor Pharmaceuticals, Inc.
CIK
CIK 1411158
Filed
Jan 25, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub